Platelet collagen receptors

Thrombosis and Haemostasis

Volumn 86, Issue 1, 2001, Pages 189-197

  Clemetson, K J ^a   Clemetson, J M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Collagen; Ig superfamily; Integrin; Platelet; Receptor

Indexed keywords

BACITRACIN; CD31 ANTIGEN; CD36 ANTIGEN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GLYCOPROTEIN; GLYCOPROTEIN IB; GLYCOPROTEIN VI; IMMUNOGLOBULIN; INTEGRIN; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

BLOOD VESSEL WALL; CELL INTERACTION; CONFERENCE PAPER; DRUG RECEPTOR BINDING; HEMOSTASIS; HUMAN; MOLECULE; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; REGULATORY MECHANISM; SHEAR RATE; SUBENDOTHELIUM; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS;

EID: 0034921326     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616217     Document Type: Conference Paper

References (91)

1. The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen
2. Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain
3. 1
4. 1
5. 1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens
6. 1 integrin-mediated platelet adhesion and platelet activation
7. 1
8. Identification of integrin collagen receptors on human melanoma cells
9. 1-associated collagen binding integrin expressed on chondrocytes
10. 1-associated integrin α-chain present in muscle tissues
11. 1 integrin) deficiency associated with a myeloproliferative disorder
12. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia
13. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder
14. 2 gene coding sequence
15. Collagen-platelet interactions: Evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins
16. 1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cγ2 in platelets
17. Rhodocetin, a novel platelet aggregation inhibitor from the venom of Calloselasma rhodostoma (Malayan pit viper): Synergistic and noncovalent interaction between its subunits
18. 1 integrin
19. 1 integrin to the induction of platelet protein tyrosine phosphorylation and aggregation
20. 1
21. 1 integrin by the metalloproteinase jararhagin compromises collagen-stimulated phosphorylation of pp 72
22. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain
23. Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist
24. Molecular cloning and sequence analysis of aggretin, a collagen-like platelet aggregation inducer
25. Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib
26. Platelets interact with soluble and insoluble collagens through characteristically different reactions
27. Integrin cytoplasmic domain-binding proteins
28. Protein disulfide isomerase activity is released by activated platelets
29. Protein disulfide isomerase mediates integrin-dependent adhesion
30. 3 has an endogenous thiol isomerase activity
31. Platelet aggregation caused by dithiothreitol
32. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets
33. 1 following ligand binding
34. Protein disulphide isomerase mediates platelet aggregation and secretion
35. 1 density
36. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: A case-control study
37. 1 might be a genetic risk factor for the development of stroke in younger patients
38. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women
39. Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting
40. 1 integrin, a platelet receptor for collagen
41. 1 is associated with increased risk of cardiovascular mortality in high-risk women
42. 1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system
43. 1 density and von Willebrand factor
44. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis
45. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia
46. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion
47. Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency
48. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcαR and the natural killer receptors
49. Cloning and expression of the platelet-specific collagen receptor glycoprotein VI
50. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: A platelet-specific collagen receptor from the immunoglobulin superfamily
51. Molecular cloning, genomic structure, chromosomal localization, and alternative splice forms of the platelet collagen receptor glycoprotein VI
52. A novel association of Fc receptor γ-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets
53. Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRγ chain
54. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice
55. Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor γ-chain
56. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor
57. Convulxin binding to platelet receptor GPVI: Competition with collagen related peptides
58. Glycoprotein VI is a major collagen receptor for platelet activation: It recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not
59. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR γ-chain. Molecular basis for CD89/FcR γ-chain association
60. Paired immunoglobulin-like receptor (PIR)-A is involved activating mast cells through its association with Fc receptor γ-chain
61. Functional association of FcεRIγ with arginine(632) of paired immunoglobulin-like receptor (PIR)-A3 in murine macrophages
62. Expression of the platelet receptor GPVI confers signaling via the Fc receptor γ-chain in response to the snake venom convulxin but not to collagen
63. Analysis of platelet adhesion to a collagen-coated surface under flow conditions: The involvement of glycoprotein VI in the platelet adhesion
64. 1-independent platelet reactivity
65. 1
66. 1
67. Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI
68. I-isolation and electron microscope studies of a potent platelet-aggregating glycoprotein from the venom of Crotalus durissus cascavella
69. 1
70. A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelets aggregation induced by both ristocetin and collagen
71. 1 (GPIa/IIa)-I-domain binding to collagen in a different manner
72. 3 activation both in platelets and a transfected Chinese hamster ovary cell system
73. 3: Studies in human platelets and transfected Chinese hamster ovary cells
74. Platelet plasma membrane glycoproteins. Identification of a proteolytic substrate for thrombin
75. Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and do not exhibit a Bernard-Soulier phenotype
76. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V
77. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V
78. Recent evidence for a role of glycoprotein V in platelet adhesion and aggregation
79. Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood
80. Analysis of CD36 binding domains: Ligand specificity controlled by dephosphorylation of an ectodomain
81. CD36 is a receptor for oxidized low density lipoprotein
82. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice
83. Platelets deficient in glycoprotein IIIb aggregate normally to collagens type I and III but not to collagen type V
84. Collagen induces normal signal transduction in platelets deficient in CD36 (platelet glycoprotein IV)
85. Molecular basis of CD36 deficiency. Evidence that a 478C→T substitution (proline90→serine) in CD36 cDNA accounts for CD36 deficiency
86. PECAM-1 (CD31) Cloning and relation to adhesion molecules of the immunoglobulin gene superfamily
87. PECAM-1: A negative regulator of platelet activation?
88. Cloning, characterization, and functional studies of a nonintegrin platelet receptor for type I collagen
89. A synthetic peptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation
90. Role of the recombinant protein of the platelet receptor for type I collagen in the release of nitric oxide during platelet aggregation
91. A new platelet receptor specific to type III collagen. Type III collagen-binding protein